4//SEC Filing
FORSYTH DOUGLAS 4
Accession 0002007919-24-000040
CIK 0002007919other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:26 PM ET
Size
7.6 KB
Accession
0002007919-24-000040
Insider Transaction Report
Form 4
FORSYTH DOUGLAS
Director
Transactions
- Purchase
Common Stock
2024-08-23$14.07/sh+59,812$841,555→ 224,564 total(indirect: By Trust) - Purchase
Common Stock
2024-08-22$12.89/sh+15,188$195,773→ 164,752 total(indirect: By Trust)
Footnotes (3)
- [F1]The shares were purchased in multiple transactions at prices ranging from $12.80 to $13.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust Dated July 20, 2001.
- [F3]The shares were purchased in multiple transactions at prices ranging from $13.48 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeother
Related Parties
1- filerCIK 0001240801
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:26 PM ET
- Size
- 7.6 KB